Crexendo, Inc.
NASDAQ:CXDOTelecommunications Services
-$0.06 today
- Market cap
- $156.20M
- Beta
- 1.07
- P/E (TTM)
- 48.3
- EPS (TTM)
- $0.14
Volume 0.20M
Average 0.46M
CXDO Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Crexendo, Inc.NASDAQ: CXDO
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development growth accelerates
Q1 FY2026 research & development of $1.57M rose 2.9% year over year, ahead of the -1.1% change in trailing-twelve-month research & development. Sequentially, it rose 16.4% from the prior quarter. Over 3 fiscal years it compounded at +13.1% a year.
Context
- Research & development amounted to 8.4% of revenue in FY2025, down 0.7 pp from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +2.9% holds above the trailing-twelve-month pace of -1.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 5.72M USD
- Year-over-year change
- +3.0%
- 4-year CAGR
- +42.3%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.72M | +3.0% |
| FY2024 | 2024-12-31 | 5.55M | +14.2% |
| FY2023 | 2023-12-31 | 4.86M | +22.9% |
| FY2022 | 2022-12-31 | 3.96M | +183.3% |
| FY2021 | 2021-12-31 | 1.4M | — |
Research & Development vs competitors
How CXDO compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -1.1% is the 3rd highest of 4, against a peer median of +12.0%.
- Research & development amounts to 7.9% of revenue for CXDO, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2025 | CN¥69.34M CNY | -55.2% | -43.5% | 15.8% | |
| LTM Mar 2026 | €25.39M EUR | +97.2% | — | 4.5% | |
| LTM Mar 2026 | $20.72M USD | +12.0% | -1.4% | 28.2% | |
| LTM Mar 2026 | $5.76M USD | -1.1% | +13.1% | 7.9% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding CXDO) | — | +12.0% | -22.4% | 0.0% | |
Competitors are the stored peer set for CXDO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 28.09M | 37.55M | 53.2M | 60.84M | 68.17M |
| Cost of Revenue | 10.66M | 13.68M | 21.56M | 23.1M | 25.26M |
| Gross Profit | 17.43M | 23.87M | 31.64M | 37.74M | 42.9M |
| Gross Margin | 62.1% | 63.6% | 59.5% | 62.0% | 62.9% |
| Research & Development | 1.4M | 3.96M | 4.86M | 5.55M | 5.72M |
| Selling, General & Admin | 18.85M | 24.63M | 28.46M | 30.37M | 32.49M |
| Operating Expenses | 20.24M | 61.26M | 33.32M | 35.92M | 38.21M |
| Depreciation & Amortization | 1.63M | 2.75M | 3.57M | 3.33M | 3.3M |
| EBITDA | (1.2M) | (33.35M) | 3.42M | 5.26M | 8.69M |
| EBITDA Margin | -4.3% | -88.8% | 6.4% | 8.6% | 12.7% |
| Operating Income | (2.81M) | (37.39M) | (1.69M) | 1.82M | 4.69M |
| Operating Margin | -10.0% | -99.6% | -3.2% | 3.0% | 6.9% |
| Interest Income | 1K | 0 | 2K | 191K | 637K |
| Interest Expense | 84K | 78K | 115K | 42K | 19K |
| Other Income / Expenses | (100K) | 1.22M | 1.43M | 65K | 681K |
| Income Before Tax | (2.91M) | (36.18M) | (264K) | 1.89M | 5.37M |
| Pre-Tax Margin | -10.4% | -96.3% | -0.5% | 3.1% | 7.9% |
| Income Tax Expense | (465K) | (762K) | 98K | 212K | 300K |
| Net Income | (2.45M) | (35.41M) | (362K) | 1.68M | 5.07M |
| Net Margin | -8.7% | -94.3% | -0.7% | 2.8% | 7.4% |
| EPS (Basic) | (0.12) | (1.54) | (0.01) | 0.06 | 0.17 |
| EPS (Diluted) | (0.12) | (1.54) | (0.01) | 0.06 | 0.16 |
| Weighted Avg Shares | 20.28M | 22.94M | 25.94M | 26.76M | 29.68M |
| Weighted Avg Shares (Diluted) | 20.28M | 22.94M | 25.94M | 30.02M | 31.64M |
Crexendo, Inc.
NASDAQ:CXDO
Intrinsic Alpha fair value
Locked
Current Price
$4.68
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.